Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa
Clinical trial NCT01838499 · TERMINATED
Trial details
- NCT number
- NCT01838499
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-10-01
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.